aDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China bHong Kong Institute of Diabetes and Obesity, The Chinese University of ...
Introduction: Approximately 70% of patients who are at high or very high risk for an atherosclerotic CV event fail to achieve their treatment targets. Laroprovstat (AZD0780), an oral small-molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results